Bukwang Pharmaceutical Co., Ltd. (KRX:003000)

Revenue by Product

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005	1987 - 2003
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Mar 31, 2011	Mar 31, 2009	Mar 31, 2008	Mar 31, 2007	Mar 31, 2006	Mar 31, 2005	Mar 31, 2004	1987 - 2003
Pharmaceutical	162.68B																				Upgrade
Pharmaceutical Growth	25.64%																				Upgrade
Consolidated Adjustment	-2.60B																				Upgrade
Consolidated Adjustment Growth	-26.99%																				Upgrade

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005	1987 - 2003
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Mar 31, 2011	Mar 31, 2009	Mar 31, 2008	Mar 31, 2007	Mar 31, 2006	Mar 31, 2005	Mar 31, 2004	1987 - 2003
South Korea	160.05B																				Upgrade
South Korea Growth	27.25%																				Upgrade
Overseas	37.76M																				Upgrade
Overseas Growth	-74.80%																				Upgrade